PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment - Pharmala Biotech Hldgs (OTC:PMBHF)
Canadian biotech company PharmAla Biotech Holdings (OTC: PMBHF) has filed a patent covering composition of matter of Novel Chemical Entity (NCE) PharmAla-1. 
New South Wales Nick Kadysh William Fantegrossi Harpreet Kaur Sciences In Prof University Of Windsor
Source: benzinga.com